Bingling Zhong

524 total citations
14 papers, 384 citations indexed

About

Bingling Zhong is a scholar working on Molecular Biology, Toxicology and Organic Chemistry. According to data from OpenAlex, Bingling Zhong has authored 14 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Toxicology and 2 papers in Organic Chemistry. Recurrent topics in Bingling Zhong's work include Bioactive Compounds and Antitumor Agents (5 papers), Cell death mechanisms and regulation (4 papers) and Synthesis and biological activity (2 papers). Bingling Zhong is often cited by papers focused on Bioactive Compounds and Antitumor Agents (5 papers), Cell death mechanisms and regulation (4 papers) and Synthesis and biological activity (2 papers). Bingling Zhong collaborates with scholars based in Macao, China and Sri Lanka. Bingling Zhong's co-authors include Xiuping Chen, Ying Hou, Jin‐Jian Lu, Jie Yu, Nana Ai, Wei Ge, Shaojing Li, Yang Lü, Jiahong Lu and Jinping Pang and has published in prestigious journals such as Free Radical Biology and Medicine, Pharmacology & Therapeutics and Biochemical Pharmacology.

In The Last Decade

Bingling Zhong

14 papers receiving 379 citations

Peers

Bingling Zhong

PRM

ONCOL

CAM

Qian Zuo China

Yiming Zhang China

Zhang Li China

Lu Wen China

Young Hee Maeng South Korea

Lin Ye China

Qin Dong China

Lei Wan China

Jianyang Hu China

Qian Zuo China

Bingling Zhong

206 ×0.9

56 ×0.6

PRM

78 ×1.0

72 ×1.8

ONCOL

26 ×0.7

CAM

Citations per year, relative to Bingling Zhong Bingling Zhong (= 1×) peers Qian Zuo

Countries citing papers authored by Bingling Zhong

Since Specialization

Citations

This map shows the geographic impact of Bingling Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingling Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingling Zhong more than expected).

Fields of papers citing papers by Bingling Zhong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingling Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingling Zhong. The network helps show where Bingling Zhong may publish in the future.

Co-authorship network of co-authors of Bingling Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Bingling Zhong. A scholar is included among the top collaborators of Bingling Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingling Zhong. Bingling Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Zhong, Bingling, et al.. (2024). SP600125, a selective JNK inhibitor, is a potent inhibitor of NAD(P)H: quinone oxidoreductase 1 (NQO1). Acta Pharmacologica Sinica. 46(4). 1137–1144. 2 indexed citations

Hou, Ying, Bingling Zhong, Lin Zhao, et al.. (2024). A small molecule cryptotanshinone induces non-enzymatic NQO1-dependent necrosis in cancer cells through the JNK1/2/Iron/PARP/calcium pathway. Acta Pharmaceutica Sinica B. 15(2). 991–1006. 1 indexed citations

Zhong, Bingling, Ying Hou, Baojian Guo, et al.. (2023). Fighting cancer by triggering non-canonical mitochondrial permeability transition-driven necrosis through reactive oxygen species induction. Free Radical Biology and Medicine. 202. 35–45. 15 indexed citations

Zhao, Lin, Bingling Zhong, Yanyan Zhu, et al.. (2023). Nitrovin (difurazone), an antibacterial growth promoter, induces ROS-mediated paraptosis-like cell death by targeting thioredoxin reductase 1 (TrxR1). Biochemical Pharmacology. 210. 115487–115487. 15 indexed citations

Yu, Jie, Bingling Zhong, Lin Zhao, et al.. (2023). Fighting drug-resistant lung cancer by induction of NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated ferroptosis. Drug Resistance Updates. 70. 100977–100977. 53 indexed citations

Zhong, Bingling, Lin Zhao, Jie Yu, et al.. (2022). Exogenous iron impairs the anti-cancer effect of ascorbic acid both in vitro and in vivo. Journal of Advanced Research. 46. 149–158. 15 indexed citations

Hou, Ying, Rong Liu, Bingling Zhong, et al.. (2021). Nannocystin ax, an eEF1A inhibitor, induces G1 cell cycle arrest and caspase-independent apoptosis through cyclin D1 downregulation in colon cancer in vivo. Pharmacological Research. 173. 105870–105870. 20 indexed citations

Zhong, Bingling, Jie Yu, Ying Hou, et al.. (2021). A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis. Free Radical Biology and Medicine. 166. 104–115. 18 indexed citations

Yu, Jie, et al.. (2021). Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors Necrostatin-1 (Nec-1) and 7-Cl-O-Nec-1 (Nec-1s) are potent inhibitors of NAD(P)H: Quinone oxidoreductase 1 (NQO1). Free Radical Biology and Medicine. 173. 64–69. 8 indexed citations

10.

Zhong, Bingling, Ying Hou, Ligen Lin, et al.. (2021). Therapeutic potential of isobavachalcone, a natural flavonoid, in murine experimental colitis by inhibiting NF‐κB p65. Phytotherapy Research. 35(10). 5861–5870. 24 indexed citations

11.

Yu, Jie, Bingling Zhong, Lida Du, et al.. (2020). Induction of programmed necrosis: A novel anti-cancer strategy for natural compounds. Pharmacology & Therapeutics. 214. 107593–107593. 55 indexed citations

12.

Yu, Jie, Bingling Zhong, Long Jin, et al.. (2020). 2-Methoxy-6-acetyl-7-methyljuglone (MAM) induced programmed necrosis in glioblastoma by targeting NAD(P)H: Quinone oxidoreductase 1 (NQO1). Free Radical Biology and Medicine. 152. 336–347. 30 indexed citations

13.

Chen, Xiuping, Bingling Zhong, Jiahong Lu, et al.. (2019). Pharmacological activities of dihydrotanshinone I, a natural product from Salvia miltiorrhiza Bunge. Pharmacological Research. 145. 104254–104254. 69 indexed citations

14.

Li, Dan, Wenfang Zhou, Jinping Pang, et al.. (2018). A magic drug target: Androgen receptor. Medicinal Research Reviews. 39(5). 1485–1514. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact